Download PDF
Semin Neurol 2017; 37(03): 339-350
DOI: 10.1055/s-0037-1603914
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Cerebral Arteriopathies, Venous Thrombosis, and Migraine

Erica C. S. Camargo
1   Stroke Service, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts
2   Department of Neurology, Harvard Medical School, Boston, Massachusetts
,
Aneesh B. Singhal
1   Stroke Service, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts
2   Department of Neurology, Harvard Medical School, Boston, Massachusetts
› Author Affiliations
Further Information

Publication History

Publication Date:
31 July 2017 (online)

    Permissions and Reprints

Abstract

In this article, the authors review stroke preventive strategies in a diverse group of conditions, namely the nonatherosclerotic cerebral arteriopathies, migraine-associated or migraine-induced stroke, and cerebral venous sinus thrombosis. Although these conditions are less common causes of stroke in the aggregate, they are frequent causes of stroke in teenagers and young adults. Aside from posing unique diagnostic challenges, their management is limited by the absence of randomized clinical trials or high-level evidence that is specific to these conditions. Therapeutic decision-making is largely based on expert opinion, clinical experience, and retrospective studies; it is often empiric. It remains uncertain whether otherwise routine secondary stroke-preventive strategies, such as long-term antiplatelet treatment, lipid-lowering medications, and antihypertensive agents, are applicable to patients with stroke from a cerebral arteriopathy or migraine-associated stroke.

Keywords

ischemic stroke - migraine - cerebral arteritis - cerebral venous thrombosis - stroke prevention
 

  • References

  • 1 George MG, Tong X, Kuklina EV, Labarthe DR. Trends in stroke hospitalizations and associated risk factors among children and young adults, 1995-2008. Ann Neurol 2011; 70 (05) 713-721
    CrossrefPubMedGoogle Scholar
  • 2 Kissela BM, Khoury JC, Alwell K. , et al. Age at stroke: temporal trends in stroke incidence in a large, biracial population. Neurology 2012; 79 (17) 1781-1787
    CrossrefPubMedGoogle Scholar
  • 3 Rutten-Jacobs LC, Maaijwee NA, Arntz RM. , et al. Long-term risk of recurrent vascular events after young stroke: The FUTURE study. Ann Neurol 2013; 74 (04) 592-601
    CrossrefPubMedGoogle Scholar
  • 4 Tibæk M, Dehlendorff C, Jørgensen HS, Forchhammer HB, Johnsen SP, Kammersgaard LP. Increasing incidence of hospitalization for stroke and transient ischemic attack in young adults: a registry-based study. J Am Heart Assoc 2016; 5 (05) 5
    PubMedGoogle Scholar
  • 5 Rutten-Jacobs LC, Arntz RM, Maaijwee NA. , et al. Long-term mortality after stroke among adults aged 18 to 50 years. JAMA 2013; 309 (11) 1136-1144
    CrossrefPubMedGoogle Scholar
  • 6 Ji R, Schwamm LH, Pervez MA, Singhal AB. Ischemic stroke and transient ischemic attack in young adults: risk factors, diagnostic yield, neuroimaging, and thrombolysis. JAMA Neurol 2013; 70 (01) 51-57
    CrossrefPubMedGoogle Scholar
  • 7 Putaala J, Haapaniemi E, Kaste M, Tatlisumak T. How does number of risk factors affect prognosis in young patients with ischemic stroke?. Stroke 2012; 43 (02) 356-361
    CrossrefPubMedGoogle Scholar
  • 8 Rutten-Jacobs LC, Maaijwee NA, Arntz RM. , et al. Risk factors and prognosis of young stroke. The FUTURE study: a prospective cohort study. Study rationale and protocol. BMC Neurol 2011; 11: 109
    CrossrefPubMedGoogle Scholar
  • 9 von Sarnowski B, Schminke U, Tatlisumak T. , et al; sifap1 investigators. Prevalence of stenoses and occlusions of brain-supplying arteries in young stroke patients. Neurology 2013; 80 (14) 1287-1294
    CrossrefPubMedGoogle Scholar
  • 10 Putaala J, Metso AJ, Metso TM. , et al. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke 2009; 40 (04) 1195-1203
    CrossrefPubMedGoogle Scholar
  • 11 Yesilot Barlas N, Putaala J, Waje-Andreassen U. , et al. Etiology of first-ever ischaemic stroke in European young adults: the 15 cities young stroke study. Eur J Neurol 2013; 20 (11) 1431-1439
    CrossrefPubMedGoogle Scholar
  • 12 Mackay MT, Wiznitzer M, Benedict SL, Lee KJ, Deveber GA, Ganesan V. ; International Pediatric Stroke Study Group. Arterial ischemic stroke risk factors: the International Pediatric Stroke Study. Ann Neurol 2011; 69 (01) 130-140
    CrossrefPubMedGoogle Scholar
  • 13 Debette S, Compter A, Labeyrie MA. , et al. Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection. Lancet Neurol 2015; 14 (06) 640-654
    CrossrefPubMedGoogle Scholar
  • 14 Lyrer PA, Brandt T, Metso TM. , et al; Cervical Artery Dissection and Ischemic Stroke Patients (CADISP) Study Group. Clinical import of Horner syndrome in internal carotid and vertebral artery dissection. Neurology 2014; 82 (18) 1653-1659
    CrossrefPubMedGoogle Scholar
  • 15 Schwedt TJ, Matharu MS, Dodick DW. Thunderclap headache. Lancet Neurol 2006; 5 (07) 621-631
    CrossrefPubMedGoogle Scholar
  • 16 Georgiadis D, Lanczik O, Schwab S. , et al. IV thrombolysis in patients with acute stroke due to spontaneous carotid dissection. Neurology 2005; 64 (09) 1612-1614
    CrossrefPubMedGoogle Scholar
  • 17 Engelter ST, Rutgers MP, Hatz F. , et al. Intravenous thrombolysis in stroke attributable to cervical artery dissection. Stroke 2009; 40 (12) 3772-3776
    CrossrefPubMedGoogle Scholar
  • 18 Qureshi AI, Chaudhry SA, Hassan AE. , et al. Thrombolytic treatment of patients with acute ischemic stroke related to underlying arterial dissection in the United States. Arch Neurol 2011; 68 (12) 1536-1542
    CrossrefPubMedGoogle Scholar
  • 19 Engelter ST, Dallongeville J, Kloss M. , et al; Cervical Artery Dissection and Ischaemic Stroke Patients-Study Group. Thrombolysis in cervical artery dissection--data from the Cervical Artery Dissection and Ischaemic Stroke Patients (CADISP) database. Eur J Neurol 2012; 19 (09) 1199-1206
    CrossrefPubMedGoogle Scholar
  • 20 Ohta H, Natarajan SK, Hauck EF. , et al. Endovascular stent therapy for extracranial and intracranial carotid artery dissection: single-center experience. J Neurosurg 2011; 115 (01) 91-100
    CrossrefPubMedGoogle Scholar
  • 21 Lyrer P, Engelter S. Antithrombotic drugs for carotid artery dissection. Stroke 2004; 35 (02) 613-614
    CrossrefPubMedGoogle Scholar
  • 22 Georgiadis D, Arnold M, von Buedingen HC. , et al. Aspirin vs anticoagulation in carotid artery dissection: a study of 298 patients. Neurology 2009; 72 (21) 1810-1815
    CrossrefPubMedGoogle Scholar
  • 23 Markus HS, Hayter E, Levi C, Feldman A, Venables G, Norris J. ; CADISS trial investigators. Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial. Lancet Neurol 2015; 14 (04) 361-367
    CrossrefPubMedGoogle Scholar
  • 24 Debette S, Metso T, Pezzini A. , et al; Cervical Artery Dissection and Ischemic Stroke Patients (CADISP) Group. Association of vascular risk factors with cervical artery dissection and ischemic stroke in young adults. Circulation 2011; 123 (14) 1537-1544
    CrossrefPubMedGoogle Scholar
  • 25 Biller J, Sacco RL, Albuquerque FC. , et al; American Heart Association Stroke Council. Cervical arterial dissections and association with cervical manipulative therapy: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014; 45 (10) 3155-3174
    CrossrefPubMedGoogle Scholar
  • 26 Switzer JA, Hess DC, Nichols FT, Adams RJ. Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol 2006; 5 (06) 501-512
    CrossrefPubMedGoogle Scholar
  • 27 Earley CJ, Kittner SJ, Feeser BR. , et al. Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study. Neurology 1998; 51 (01) 169-176
    CrossrefPubMedGoogle Scholar
  • 28 Ohene-Frempong K, Weiner SJ, Sleeper LA. , et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998; 91 (01) 288-294
    PubMedGoogle Scholar
  • 29 Powars D, Wilson B, Imbus C, Pegelow C, Allen J. The natural history of stroke in sickle cell disease. Am J Med 1978; 65 (03) 461-471
    CrossrefPubMedGoogle Scholar
  • 30 Moser FG, Miller ST, Bello JA. , et al. The spectrum of brain MR abnormalities in sickle-cell disease: a report from the Cooperative Study of Sickle Cell Disease. AJNR Am J Neuroradiol 1996; 17 (05) 965-972
    PubMedGoogle Scholar
  • 31 Steen RG, Emudianughe T, Hankins GM. , et al. Brain imaging findings in pediatric patients with sickle cell disease. Radiology 2003; 228 (01) 216-225
    CrossrefPubMedGoogle Scholar
  • 32 Pegelow CH, Macklin EA, Moser FG. , et al. Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood 2002; 99 (08) 3014-3018
    CrossrefPubMedGoogle Scholar
  • 33 Adams R, McKie V, Nichols F. , et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med 1992; 326 (09) 605-610
    CrossrefPubMedGoogle Scholar
  • 34 Kossorotoff M, Brousse V, Grevent D. , et al. Cerebral haemorrhagic risk in children with sickle-cell disease. Dev Med Child Neurol 2015; 57 (02) 187-193
    CrossrefPubMedGoogle Scholar
  • 35 Hariman LM, Griffith ER, Hurtig AL, Keehn MT. Functional outcomes of children with sickle-cell disease affected by stroke. Arch Phys Med Rehabil 1991; 72 (07) 498-502
    PubMedGoogle Scholar
  • 36 Roach ES, Golomb MR, Adams R. , et al; American Heart Association Stroke Council; Council on Cardiovascular Disease in the Young. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke 2008; 39 (09) 2644-2691
    CrossrefPubMedGoogle Scholar
  • 37 Adams RJ, McKie VC, Hsu L. , et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998; 339 (01) 5-11
    CrossrefPubMedGoogle Scholar
  • 38 Armstrong-Wells J, Grimes B, Sidney S. , et al. Utilization of TCD screening for primary stroke prevention in children with sickle cell disease. Neurology 2009; 72 (15) 1316-1321
    CrossrefPubMedGoogle Scholar
  • 39 Goldstein LB, Bushnell CD, Adams RJ. , et al; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Epidemiology and Prevention; Council for High Blood Pressure Research; Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42 (02) 517-584
    CrossrefPubMedGoogle Scholar
  • 40 Russell MO, Goldberg HI, Hodson A. , et al. Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood 1984; 63 (01) 162-169
    PubMedGoogle Scholar
  • 41 Kelly S, Quirolo K, Marsh A, Neumayr L, Garcia A, Custer B. Erythrocytapheresis for chronic transfusion therapy in sickle cell disease: survey of current practices and review of the literature. Transfusion 2016; 56 (11) 2877-2888
    CrossrefPubMedGoogle Scholar
  • 42 Adams RJ, Brambilla D. ; Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med 2005; 353 (26) 2769-2778
    CrossrefPubMedGoogle Scholar
  • 43 Abboud MR, Yim E, Musallam KM, Adams RJ. ; STOP II Study Investigators. Discontinuing prophylactic transfusions increases the risk of silent brain infarction in children with sickle cell disease: data from STOP II. Blood 2011; 118 (04) 894-898
    CrossrefPubMedGoogle Scholar
  • 44 Ware RE, Helms RW. ; SWiTCH Investigators. Stroke With Transfusions Changing to Hydroxyurea (SWiTCH). Blood 2012; 119 (17) 3925-3932
    CrossrefPubMedGoogle Scholar
  • 45 Ware RE, Davis BR, Schultz WH. , et al. Hydroxycarbamide versus Chronic Transfusion for Maintenance of Transcranial Doppler Flow Velocities in Children With Sickle Cell Anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial. Lancet 2016; 387 (10019): 661-670
    CrossrefPubMedGoogle Scholar
  • 46 Walters MC, Patience M, Leisenring W. , et al. Bone marrow transplantation for sickle cell disease. N Engl J Med 1996; 335 (06) 369-376
    CrossrefPubMedGoogle Scholar
  • 47 Hall EM, Leonard J, Smith JL. , et al. Reduction in overt and silent stroke recurrence rate following cerebral revascularization surgery in children with sickle cell disease and severe cerebral vasculopathy. Pediatr Blood Cancer 2016; 63 (08) 1431-1437
    CrossrefPubMedGoogle Scholar
  • 48 Singhal AB. Cerebral vasoconstriction syndromes. Top Stroke Rehabil 2004; 11 (02) 1-6
    PubMedGoogle Scholar
  • 49 Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB. Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med 2007; 146 (01) 34-44
    CrossrefPubMedGoogle Scholar
  • 50 Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser MG. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 2007; 130 (Pt 12): 3091-3101
    CrossrefPubMedGoogle Scholar
  • 51 Williams TL, Lukovits TG, Harris BT, Harker Rhodes C. A fatal case of postpartum cerebral angiopathy with literature review. Arch Gynecol Obstet 2007; 275 (01) 67-77
    CrossrefPubMedGoogle Scholar
  • 52 Singhal AB, Topcuoglu MA, Fok JW. , et al. Reversible cerebral vasoconstriction syndromes and primary angiitis of the central nervous system: clinical, imaging, and angiographic comparison. Ann Neurol 2016; 79 (06) 882-894
    CrossrefPubMedGoogle Scholar
  • 53 Singhal AB, Hajj-Ali RA, Topcuoglu MA, Fok J, Bena J, Yang D, Calabrese LH. Reversible cerebral vasoconstriction syndromes: analysis of 139 cases. Arch Neurol 2011; 68 (08) 1005-1012
    CrossrefPubMedGoogle Scholar
  • 54 Chen SP, Fuh JL, Wang SJ. , et al. Magnetic resonance angiography in reversible cerebral vasoconstriction syndromes. Ann Neurol 2010; 67 (05) 648-656
    PubMedGoogle Scholar
  • 55 Singhal AB. Postpartum angiopathy with reversible posterior leukoencephalopathy. Arch Neurol 2004; 61 (03) 411-416
    CrossrefPubMedGoogle Scholar
  • 56 Topcuoglu MA, Kursun O, Singhal AB. Coexisting vascular lesions in reversible cerebral vasoconstriction syndrome. Cephalalgia 2017; 37 (01) 29-35
    CrossrefPubMedGoogle Scholar
  • 57 Topcuoglu MA, McKee KE, Singhal AB. Gender and hormonal influences in reversible cerebral vasoconstriction syndrome. European Stroke Journal 2016; 1: 199-204
    CrossrefPubMedGoogle Scholar
  • 58 Soo Y, Singhal AB, Leung T. , et al. Reversible cerebral vasoconstriction syndrome with posterior leucoencephalopathy after oral contraceptive pills. Cephalalgia 2010; 30 (01) 42-45
    CrossrefPubMedGoogle Scholar
  • 59 Chatterjee N, Domoto-Reilly K, Fecci PE, Schwamm LH, Singhal AB. Licorice-associated reversible cerebral vasoconstriction with PRES. Neurology 2010; 75 (21) 1939-1941
    CrossrefPubMedGoogle Scholar
  • 60 Topcuoglu MA, Singhal AB. Hemorrhagic reversible cerebral vasoconstriction syndrome: features and mechanisms. Stroke 2016; 47 (07) 1742-1747
    CrossrefPubMedGoogle Scholar
  • 61 Hajj-Ali RA, Singhal AB, Benseler S, Molloy E, Calabrese LH. Primary angiitis of the CNS. Lancet Neurol 2011; 10 (06) 561-572
    CrossrefPubMedGoogle Scholar
  • 62 Muehlschlegel S, Kursun O, Topcuoglu MA, Fok J, Singhal AB. Differentiating reversible cerebral vasoconstriction syndrome with subarachnoid hemorrhage from other causes of subarachnoid hemorrhage. JAMA Neurol 2013; 70 (10) 1254-1260
    PubMedGoogle Scholar
  • 63 Singhal AB, Topcuoglu MA. Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome. Neurology 2017; 88 (03) 228-236
    CrossrefPubMedGoogle Scholar
  • 64 Singhal AB, Caviness VS, Begleiter AF, Mark EJ, Rordorf G, Koroshetz WJ. Cerebral vasoconstriction and stroke after use of serotonergic drugs. Neurology 2002; 58 (01) 130-133
    CrossrefPubMedGoogle Scholar
  • 65 Singhal AB. Reversible cerebral vasoconstriction syndromes: what the cardiologist should know. Curr Treat Options Cardiovasc Med 2014; 16 (03) 290
    CrossrefPubMedGoogle Scholar
  • 66 Katz BS, Fugate JE, Ameriso SF. , et al. Clinical worsening in reversible cerebral vasoconstriction syndrome. JAMA Neurol 2014; 71 (01) 68-73
    CrossrefPubMedGoogle Scholar
  • 67 Singhal AB, Kimberly WT, Schaefer PW, Hedley-Whyte ET. Case records of the Massachusetts General Hospital. Case 8-2009. A 36-year-old woman with headache, hypertension, and seizure 2 weeks post partum. N Engl J Med 2009; 360 (11) 1126-1137
    CrossrefPubMedGoogle Scholar
  • 68 Chen SP, Fuh JL, Lirng JF, Wang YF, Wang SJ. Recurrence of reversible cerebral vasoconstriction syndrome: a long-term follow-up study. Neurology 2015; 84 (15) 1552-1558
    CrossrefPubMedGoogle Scholar
  • 69 John S, Singhal AB, Calabrese L. , et al. Long-term outcomes after reversible cerebral vasoconstriction syndrome. Cephalalgia 2016; 36 (04) 387-394
    CrossrefPubMedGoogle Scholar
  • 70 Salvarani C, Brown Jr RD, Calamia KT. , et al. Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 2007; 62 (05) 442-451
    CrossrefPubMedGoogle Scholar
  • 71 de Boysson H, Zuber M, Naggara O. , et al; French Vasculitis Study Group and the French NeuroVascular Society. Primary angiitis of the central nervous system: description of the first fifty-two adults enrolled in the French cohort of patients with primary vasculitis of the central nervous system. Arthritis Rheumatol 2014; 66 (05) 1315-1326
    CrossrefPubMedGoogle Scholar
  • 72 Miller DV, Salvarani C, Hunder GG. , et al. Biopsy findings in primary angiitis of the central nervous system. Am J Surg Pathol 2009; 33 (01) 35-43
    CrossrefPubMedGoogle Scholar
  • 73 Molloy ES, Singhal AB, Calabrese LH. Tumour-like mass lesion: an under-recognised presentation of primary angiitis of the central nervous system. Ann Rheum Dis 2008; 67 (12) 1732-1735
    CrossrefPubMedGoogle Scholar
  • 74 Scolding NJ, Joseph F, Kirby PA. , et al. Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain 2005; 128 (Pt 3): 500-515
    CrossrefPubMedGoogle Scholar
  • 75 Topcuoglu MA, Jha RM, George J, Frosch MP, Singhal AB. Hemorrhagic primary CNS angiitis and vasoconstrictive drug exposure. Neurol Clin Pract 2017; 7 (01) 26-34
    CrossrefPubMedGoogle Scholar
  • 76 Hutchinson C, Elbers J, Halliday W. , et al. Treatment of small vessel primary CNS vasculitis in children: an open-label cohort study. Lancet Neurol 2010; 9 (11) 1078-1084
    CrossrefPubMedGoogle Scholar
  • 77 Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet 2008; 372 (9634): 234-245
    CrossrefPubMedGoogle Scholar
  • 78 Caselli RJ, Hunder GG, Whisnant JP. Neurologic disease in biopsy-proven giant cell (temporal) arteritis. Neurology 1988; 38 (03) 352-359
    CrossrefPubMedGoogle Scholar
  • 79 Villiger PM, Adler S, Kuchen S. , et al. Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet 2016; 387 (10031): 1921-1927
    CrossrefPubMedGoogle Scholar
  • 80 Mahr AD, Jover JA, Spiera RF. , et al. Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis. Arthritis Rheum 2007; 56 (08) 2789-2797
    CrossrefPubMedGoogle Scholar
  • 81 Susac JO. Susac's syndrome: the triad of microangiopathy of the brain and retina with hearing loss in young women. Neurology 1994; 44 (04) 591-593
    CrossrefPubMedGoogle Scholar
  • 82 Mateen FJ, Zubkov AY, Muralidharan R. , et al. Susac syndrome: clinical characteristics and treatment in 29 new cases. Eur J Neurol 2012; 19 (06) 800-811
    CrossrefPubMedGoogle Scholar
  • 83 Bousser M, Tournier-Lasserve E. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: from stroke to vessel wall physiology. J Neurol Neurosurg Psychiatry 2001; 70 (03) 285-287
    CrossrefPubMedGoogle Scholar
  • 84 Chabriat H, Pappata S, Ostergaard L. , et al. Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking. Stroke 2000; 31 (08) 1904-1912
    CrossrefPubMedGoogle Scholar
  • 85 Dichgans M, Markus HS, Salloway S. , et al. Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL. Lancet Neurol 2008; 7 (04) 310-318
    CrossrefPubMedGoogle Scholar
  • 86 Kolodny E, Fellgiebel A, Hilz MJ. , et al. Cerebrovascular involvement in Fabry disease: current status of knowledge. Stroke 2015; 46 (01) 302-313
    CrossrefPubMedGoogle Scholar
  • 87 Hallemeier CL, Rich KM, Grubb Jr RL. , et al. Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke 2006; 37 (06) 1490-1496
    CrossrefPubMedGoogle Scholar
  • 88 Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol 2007; 6 (02) 162-170
    CrossrefPubMedGoogle Scholar
  • 89 Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F. ; ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004; 35 (03) 664-670
    CrossrefPubMedGoogle Scholar
  • 90 Einhäupl KM, Villringer A, Meister W. , et al. Heparin treatment in sinus venous thrombosis. Lancet 1991; 338 (8767): 597-600
    CrossrefPubMedGoogle Scholar
  • 91 de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999; 30 (03) 484-488
    CrossrefPubMedGoogle Scholar
  • 92 Ferro JM, Crassard I, Coutinho JM. , et al; Second International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT 2) Investigators. Decompressive surgery in cerebrovenous thrombosis: a multicenter registry and a systematic review of individual patient data. Stroke 2011; 42 (10) 2825-2831
    CrossrefPubMedGoogle Scholar
  • 93 Kurth T, Winter AC, Eliassen AH. , et al. Migraine and risk of cardiovascular disease in women: prospective cohort study. BMJ 2016; 353: i2610
    PubMedGoogle Scholar
  • 94 Kurth T, Chabriat H, Bousser MG. Migraine and stroke: a complex association with clinical implications. Lancet Neurol 2012; 11 (01) 92-100
    CrossrefPubMedGoogle Scholar
  • 95 Welch KM. Relationship of stroke and migraine. Neurology 1994; 44 (10) (Suppl. 07) S33-S36
    PubMedGoogle Scholar